Charities and patients welcome NICE decision to reconsider the removal of a “lifeline” cell therapy from the NHS
Stem cell charity Anthony Nolan, together with Blood Cancer UK and Lymphoma Action, welcome the decision by NICE to reconsider the removal of the CAR T-cell therapy Tecartus (brexucabtagene autoleucel) as a treatment for mantle cell lymphoma. After five years of Tecartus being available on the NHS in England […]
Virtual Lymphoma Management Course 2023
The Lymphoma Management Course is delivered virtually, and comprises of four weekly sessions, covering many key topics essential for the effective management of lymphomas. The content is suitable for healthcare professionals […]
